Stage-specific Survival Has Improved for Young Breast Cancer Patients Since 2000: but Not Equally

Overview

Journal Breast Cancer Res Treat

Specialty Oncology

Date 2020 Jun 5

PMID 32495000

Citations 8

Authors

Cassia Bree Trewin

Anna Louise Viktoria Johansson

Kirsti Vik Hjerkind

Bjorn Heine Strand

Cecilie Essholt Kiserud

Giske Ursin

Affiliations

Soon will be listed here.

Abstract

Purpose: The stage-specific survival of young breast cancer patients has improved, likely due to diagnostic and treatment advances. We addressed whether survival improvements have reached all socioeconomic groups in a country with universal health care and national treatment guidelines.

Methods: Using Norwegian registry data, we assessed stage-specific breast cancer survival by education and income level of 7501 patients (2317 localized, 4457 regional, 233 distant and 494 unknown stage) aged 30-48 years at diagnosis during 2000-2015. Using flexible parametric models and national life tables, we compared excess mortality up to 12 years from diagnosis and 5-year relative survival trends, by education and income as measures of socioeconomic status (SES).

Results: Throughout 2000-2015, regional and distant stage 5-year relative survival improved steadily for patients with high education and high income (high SES), but not for patients with low education and low income (low SES). Regional stage 5-year relative survival improved from 85 to 94% for high SES patients (9% change; 95% confidence interval: 6, 13%), but remained at 84% for low SES patients (0% change; - 12, 12%). Distant stage 5-year relative survival improved from 22 to 58% for high SES patients (36% change; 24, 49%), but remained at 11% for low SES patients (0% change; - 19, 19%).

Conclusions: Regional and distant stage breast cancer survival has improved markedly for high SES patients, but there has been little survival gain for low SES patients. Socioeconomic status matters for the stage-specific survival of young breast cancer patients, even with universal health care.

Citing Articles

Educational disparities in cancer incidence, stage, and survival in Oslo.

Al-Rammahy A, Fadum E, Nilssen Y, Larsen I, Hem E, Bringedal B Res Health Serv Reg. 2024; 3(1):1.

PMID: 39177868 PMC: 11281764. DOI: 10.1007/s43999-024-00037-x.

Effectiveness of increasing the scalp cooling duration to prevent alopecia during adjuvant chemotherapy for breast cancer: a randomized pilot study.

Carton E, Blas A, Perret C, Le Bihan M Support Care Cancer. 2024; 32(7):410.

PMID: 38839667 PMC: 11153286. DOI: 10.1007/s00520-024-08579-z.

Social Representativeness and Intervention Adherence-A Systematic Review of Clinical Physical Activity Trials in Breast Cancer Patients.

Stalsberg R, Darvik M Int J Public Health. 2024; 69:1607002.

PMID: 38784387 PMC: 11111874. DOI: 10.3389/ijph.2024.1607002.

The contribution of prognostic factors to socio-demographic inequalities in breast cancer survival in Victoria, Australia.

Stuart G, Chamberlain J, Te Marvelde L Cancer Med. 2023; 12(14):15371-15383.

PMID: 37458115 PMC: 10417162. DOI: 10.1002/cam4.6092.

Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the Netherlands.

van Maaren M, Rachet B, Sonke G, Mauguen A, Rondeau V, Siesling S Cancer Epidemiol. 2022; 77:102118.

PMID: 35131686 PMC: 9422085. DOI: 10.1016/j.canep.2022.102118.

References

Parise C, Caggiano V . Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers. J Cancer Epidemiol. 2014; 2014:469251. PMC: 4058253. DOI: 10.1155/2014/469251. View

Exarchakou A, Rachet B, Belot A, Maringe C, Coleman M . Impact of national cancer policies on cancer survival trends and socioeconomic inequalities in England, 1996-2013: population based study. BMJ. 2018; 360:k764. PMC: 5850596. DOI: 10.1136/bmj.k764. View

Matsumoto A, Jinno H, Ando T, Fujii T, Nakamura T, Saito J . Biological markers of invasive breast cancer. Jpn J Clin Oncol. 2015; 46(2):99-105. DOI: 10.1093/jjco/hyv153. View

Asli L, Myklebust T, Kvaloy S, Jetne V, Moller B, Levernes S . Factors influencing access to palliative radiotherapy: a Norwegian population-based study. Acta Oncol. 2018; 57(9):1250-1258. DOI: 10.1080/0284186X.2018.1468087. View

Rutqvist L, Bern A . Socioeconomic gradients in clinical stage at presentation and survival among breast cancer patients in the Stockholm area 1977-1997. Int J Cancer. 2006; 119(6):1433-9. DOI: 10.1002/ijc.21949. View

Frisell A, Lagergren J, Halle M, de Boniface J . Socioeconomic status differs between breast cancer patients treated with mastectomy and breast conservation, and affects patient-reported preoperative information. Breast Cancer Res Treat. 2019; 179(3):721-729. PMC: 6997274. DOI: 10.1007/s10549-019-05496-2. View

Kravdal H . Widening educational differences in cancer survival in Norway. Eur J Public Health. 2013; 24(2):270-5. DOI: 10.1093/eurpub/ckt082. View

Shepard H, Jin P, Slamon D, Pirot Z, Maneval D . Herceptin. Handb Exp Pharmacol. 2007; (181):183-219. DOI: 10.1007/978-3-540-73259-4_9. View

Ibfelt E, Dalton S, Hogdall C, Fago-Olsen C, Steding-Jessen M, Osler M . Do stage of disease, comorbidity or access to treatment explain socioeconomic differences in survival after ovarian cancer? - A cohort study among Danish women diagnosed 2005-2010. Cancer Epidemiol. 2015; 39(3):353-9. DOI: 10.1016/j.canep.2015.03.011. View

10.

Bray F, Parkin D . Evaluation of data quality in the cancer registry: principles and methods. Part I: comparability, validity and timeliness. Eur J Cancer. 2009; 45(5):747-55. DOI: 10.1016/j.ejca.2008.11.032. View

11.

Woods L, Rachet B, Coleman M . Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2005; 17(1):5-19. DOI: 10.1093/annonc/mdj007. View

12.

Ito Y, Nakaya T, Nakayama T, Miyashiro I, Ioka A, Tsukuma H . Socioeconomic inequalities in cancer survival: a population-based study of adult patients diagnosed in Osaka, Japan, during the period 1993-2004. Acta Oncol. 2014; 53(10):1423-33. DOI: 10.3109/0284186X.2014.912350. View

13.

Partridge A, Hughes M, Warner E, Ottesen R, Wong Y, Edge S . Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival. J Clin Oncol. 2016; 34(27):3308-14. DOI: 10.1200/JCO.2015.65.8013. View

14.

Slamon D, Pegram M . Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials. Semin Oncol. 2001; 28(1 Suppl 3):13-9. DOI: 10.1016/s0093-7754(01)90188-5. View

15.

Johansson A, Trewin C, Hjerkind K, Ellingjord-Dale M, Johannesen T, Ursin G . Breast cancer-specific survival by clinical subtype after 7 years follow-up of young and elderly women in a nationwide cohort. Int J Cancer. 2018; 144(6):1251-1261. DOI: 10.1002/ijc.31950. View

16.

Verma R, Bowen R, Slater S, Mihaimeed F, Jones J . Pathological and epidemiological factors associated with advanced stage at diagnosis of breast cancer. Br Med Bull. 2012; 103(1):129-45. DOI: 10.1093/bmb/lds018. View

17.

Nilssen Y, Strand T, Fjellbirkeland L, Bartnes K, Brustugun O, OConnell D . Lung cancer treatment is influenced by income, education, age and place of residence in a country with universal health coverage. Int J Cancer. 2015; 138(6):1350-60. DOI: 10.1002/ijc.29875. View

18.

Bastiaannet E, de Craen A, Kuppen P, Aarts M, van der Geest L, van de Velde C . Socioeconomic differences in survival among breast cancer patients in the Netherlands not explained by tumor size. Breast Cancer Res Treat. 2010; 127(3):721-7. DOI: 10.1007/s10549-010-1250-z. View

19.

Larsen S, Kroman N, Ibfelt E, Christensen J, Tjonneland A, Dalton S . Influence of metabolic indicators, smoking, alcohol and socioeconomic position on mortality after breast cancer. Acta Oncol. 2015; 54(5):780-8. DOI: 10.3109/0284186X.2014.998774. View

20.

Downing A, Prakash K, Gilthorpe M, Mikeljevic J, Forman D . Socioeconomic background in relation to stage at diagnosis, treatment and survival in women with breast cancer. Br J Cancer. 2007; 96(5):836-40. PMC: 2360059. DOI: 10.1038/sj.bjc.6603622. View